Life Sciences Capital

Life Sciences Capital invests from early-stage seed and startup rounds through expansion, late-stage growth, and pre-IPO. The firm also considers spin-off opportunities within the life sciences sector. This full-lifecycle approach covers companies from initial clinical concept to near-public maturity.

The firm concentrates on healthcare and life sciences, including subsectors such as medical devices, diagnostics, digital health, and pharmaceutical services. Its sector tags also include industrial technology where it intersects with healthcare applications. The mandate excludes sectors outside science-driven healthcare innovation.

Life Sciences Capital is structured as a private equity asset manager, not a family office. It raises external capital through funds rather than managing a single family's wealth. The precise ownership and fund structures have not been publicly disclosed in detail.

The firm is headquartered in Rome, Italy, and deploys capital primarily across European life sciences markets. Its Italian base gives it proximity to university research and biotech clusters domestically, while its mandate extends to regulatory and commercial opportunities across the European Union.

Named principals and the investment committee structure for Life Sciences Capital are not publicly disclosed. The firm maintains a low public profile with no published team page or LinkedIn presence. This is not unusual for small and mid-sized private equity platforms in Southern Europe.